Secondary Central Nervous System Lymphoma Registry - Charité
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorCharite University, Berlin, Germany
About this trial
The objective of the observation is to collect and document data on treatment strategies for secondary central nervous system lymphoma (SCNSL) in routine clinical practice, whether obtained in the context of clinical trials or outside of trials. In particular, the following questions will be specified:
* What therapeutic approaches are being pursued? * What is the clinical outcome of the various treatment options? * What is the frequency of serious adverse events with each therapeutic approach?
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
All patients with SCNSL
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
300 Participants
are grouped into 2 trial groupsGroup A: Cohort 1
Group B: Cohort 2
Trial outcomes
Primary outcomes
1
Description of different therapeutic regimens
Description of different therapeutic regimens
Time frame
Through study completion, an average of 3 years2
Outcome of different therapeutic regimens
Overall Survival
Time frame
Through study completion, an average of 3 years3
Outcome of different therapeutic regimens
Progression Free Survival
Time frame
Through study completion, an average of 3 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov